ESTRO 2020 Abstract book

Proffered Papers Proffered papers 21: Protons ............................................................................................................................................ (Abs. 440-445) Proffered papers 22: Radiobiological resistance mechanisms ..................................................................................... (Abs. 446-451) Proffered papers 23 : Palliation ......................................................................................................................................... (Abs. 452-457) Proffered papers 24 : Lymphoma ..................................................................................................................................... (Abs. 458-463) Proffered papers 25 - Clinical implementation of online MRgRT .................................................................................. (Abs. 464-469) Proffered papers 26: New technology .............................................................................................................................. (Abs. 470-475) Poster Highlights Poster highlights 15: Particles and microbeams ............................................................................................................. (Abs. 476-481) Poster highlights 16 RTT: Novel strategies for treatment planning and delivery ....................................................... (Abs. 482-488)

DAY 3

Teaching Lecture Cancer metabolism: a radio-oncology perspective ......................................................................................................... (Abs. 489) The treatment of anal cancer ............................................................................................................................................ (Abs. 490) Latest updates on non-metastatic nasopharyngeal carcinoma in 2020: screening, workup, and treatment paradigms .................................................................................................................................................. (Abs. 491) Validation and commissioning of AI contouring tools ................................................................................................... (Abs. 492) 4D imaging for radiation therapy using MRI and PET .................................................................................................... (Abs. 493) Quantitative Digital Pathology Biomarkers of Neoadjuvant Therapy Response in Breast Cancer ........................... (Abs. 494) Novel Radiotherapy techniques/treatments (e.g. micro beam, FLASH, etc, possibly immunotherapy) .................. (Abs. 495) Joint Symposium ESTRO-EANM: Targeting the microenvironment in radiotherapy: where are we now? ............................................. (Abs. 496-499) Symposium How to combine different treatment modalities in rectal cancer ................................................................................. (Abs. 500-503) Multidisciplinary treatment of salivary gland tumors .................................................................................................... (Abs. 504-506) Target definition and dose prescription in the era of dose painting and probabilistic planning ............................. (Abs. 507-509) Joint Symposium ESTRO-EFOMP: Artificial intelligence and image quality (with focus on benefits for RT) ........................................... (Abs. 510-512) Symposium Individualised radiotherapy ............................................................................................................................................... (Abs. 513-515) Mobility grants report back ............................................................................................................................................... (Abs. 516-520) Poster Highlights Poster highlights 17 CL : Palliation .................................................................................................................................... (Abs. 521-526) Poster highlights 18 PH: MRI guidance ............................................................................................................................. (Abs. 527-533) Poster discussion CL: Upper and Lower GI 2 .................................................................................................................................................. (Abs. 534-539) PH: Radiobiological and predictive modelling, and radiomics 2 ................................................................................... (Abs. 540-545) PH: Implementation of new techniques 2 ....................................................................................................................... (Abs. 546-551) PH: Adaptive radiotherapy and inter-fraction motion management 2 ........................................................................ (Abs. 552-557) Proffered Papers Proffered papers 27: Novel technologies ......................................................................................................................... (Abs. 558-563) Proffered papers 28 : Gynaecology .................................................................................................................................. (Abs. 564-569) Proffered papers 29 : Head and neck ............................................................................................................................... (Abs. 570-575) Proffered papers 30 - Protons and ions .......................................................................................................................... (Abs. 576-581) Proffered papers 31: Quantitative imaging and radiomics ........................................................................................... (Abs. 582-587) Proffered papers 32: Innovations in RTT practice and complex decision making ...................................................... (Abs. 588-593)